European Journal of Cancer
European Journal of Cancer is a journal indexed in SJR in Oncology and Cancer Research with an H index of 256. Journal with a Single blind Peer Review review system, and It has a price of 2655 €. The scope of the journal is focused on Cancer, Oncology, Clinical Oncology, Medicine. It has an SJR impact factor of 2,691 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 2,691.
European Journal of Cancer focuses its scope in these topics and keywords: cancer, patients, cell, advanced, tumour, colorectal, lung, carcinoma, chemotherapy, therapy, ...
Metrics
Scimago and CountryOfPapers database fields
SJR Impact
2,691
H-index
256
Docs (year)
392
Docs 3y
1795
Total refs
12786
Cites 3y
8867
Citable 3y
1519
Cites/Doc 2y
4.38
Ref/Doc
32.62
Immediate OA
2655 €
Embargoed OA
NPD
Non OA / Submission
0 €
Name good journals. Call out predatory ones.
Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.
Researcher reviews
Best articles by citations
A pure antiestrogen, IC1182,780, stimulates the growth of tamoxifen-resistant KPL-1 human breast cancer cells in female nude mice
View moreVI.5 Tamoxifen-DNA adducts in breast cancer patients
View moreCancer prevention in the year 2025
View moreCancer information: a cost-effective intervention
View moreBreast conservation in the 21st century
View moreBile duct stents: Is there an increased rate of complications in patients receiving chemotherapy?
View moreB.I.G. - is beautiful
View moreB.I.G. - brother is watching you?
View moreApoptosis of Ovarian carcinoma cells (N1) by TNF and it's possible targets
View moreAll-trans retinoic acid enhances gap junctional intercellular communication among renal epithelial cells in vitro treated with renal carcinogens
View moreAcute effects of pamidronate administration on serum levels of interleukin-6 in advanced solid tumour patients with bone metastases and their possible implications in the immunotherapy of cancer with interleukin-2
View moreActive surveillance' for stage I testis cancer
View moreAccumulation of p53 is associated with response to pre-operative chemotherapy in primary operable breast cancer
View more(111Indium-DTPA-D-Phe) octreotide scintigraphy in the diagnostic assessment of palpable breast lumps
View moreA phase III randomised study of carboplatin and amifostine (A) vs carboplatin and G-CSF in patients with inoperable non small cell lung cancer (NSCLC)
View moreA phase II study of high-dose octreotide in patients with unresectable pancreatic carcinoma
View moreA novel herpes vector for the high efficiency transduction of primary hematopoietic cells
View moreA new standard treatment for advanced premenopausal breast cancer: A meta-analysis of the Combined Hormonal Agent Trialists Group (CHAT)
View moreA high pretreatment serum level of VEGF is associated with poor outcome in small cell lung cancer
View moreA Glimpse of the Future. New Directions in the Treatment of Colorectal Cancer
View more74 O - Selective anti-leukemic potential of HLA-incompatible bone marrow transplants
View more47 P - The role of basic fibroblast growth factor (bFGF) in human non small cell lung cancer (NSCLC)
View more26 P - Monitoring of neurotoxicity of taxanes
View more163 O - Aortic infuslon (ADM, MMC, CDDP) and stop-flow (MMC, ADM) for systemically pretreated and progresslve FLGO III c and IV ovarian cancer-45 patients
View more